William Blair & Company
NEOS

William Blair & Company’s Neos Therapeutics, Inc NEOS Stock Holding History

William Blair & Company’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,400
Closed -$7K – 1886
2020
Q3 		$7K Sell
13,400
-9,500
-41% -$6.46K ﹤0.01% 1654
2020
Q2 		$16K Sell
22,900
-4,000
-15% -$3.17K ﹤0.01% 1558
2020
Q1 		$20K Buy
26,900
+10,500
+64% +$14.4K ﹤0.01% 1492
2019
Q4 		$25K Buy
+16,400
New +$24.6K ﹤0.01% 1557

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair & Company's NEOS Position: Q4 2020 in Review

William Blair & Company sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 13,400 shares — an estimated $7K sold.

William Blair & Company first reported a position in NEOS in Q4 2019 and held it in 4 quarters. The position peaked at $25K in Q4 2019. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • William Blair & Company reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • William Blair & Company sold 13,400 Neos Therapeutics, Inc shares in Q4 2020, an estimated $7K.
  • William Blair & Company first reported a position in Neos Therapeutics, Inc in Q4 2019 and held it in 4 quarters.
  • William Blair & Company's Neos Therapeutics, Inc position peaked at $25K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on William Blair & Company's 13F filing for Q4 2020, filed 9 Feb 2021.